Pediatrix Medical Group, Inc. (NYSE:MD) Stake Lessened by Clark Estates Inc. NY

Clark Estates Inc. NY cut its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 10.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 282,740 shares of the company’s stock after selling 34,260 shares during the period. Pediatrix Medical Group makes up 0.7% of Clark Estates Inc. NY’s investment portfolio, making the stock its 23rd biggest holding. Clark Estates Inc. NY’s holdings in Pediatrix Medical Group were worth $3,710,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Quest Partners LLC grew its position in Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after acquiring an additional 622 shares during the period. Parkside Financial Bank & Trust grew its stake in shares of Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after acquiring an additional 1,040 shares in the last quarter. Quarry LP raised its stake in shares of Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,662 shares in the last quarter. Smartleaf Asset Management LLC raised its stake in Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after acquiring an additional 6,090 shares during the period. Finally, FMR LLC lifted its holdings in Pediatrix Medical Group by 220.6% during the 3rd quarter. FMR LLC now owns 9,841 shares of the company’s stock worth $114,000 after purchasing an additional 6,771 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Price Performance

NYSE MD opened at $14.43 on Wednesday. The business’s fifty day moving average is $14.00 and its 200 day moving average is $13.22. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The company has a market capitalization of $1.24 billion, a PE ratio of -12.02, a price-to-earnings-growth ratio of 1.74 and a beta of 1.57. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. The firm had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. Sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analysts Set New Price Targets

MD has been the topic of a number of research analyst reports. UBS Group raised their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research note on Friday, February 21st. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Jefferies Financial Group boosted their price target on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Mizuho increased their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 19th. Finally, Truist Financial upped their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, February 21st. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.